December 2022 PMID 36555842

Dysmenorrhoea: Can Medicinal Cannabis Bring New Hope for a Collective Group of Women Suffering in Pain, Globally?

Amelia Seifalian, Julian Kenyon, Vik Khullar

Full text PDF Download social card

Mentions

Peak: 8 in Dec 2022

across 4 sources since Dec 2022

Extended reach

84,422

potential audience

Total likes

Video views

Mentions per month

Dec 2022 – Sep 2024

Where it's discussed

X / Twitter17 posts
News3 articles
Facebook2 posts
YouTube1 videos

AI synopsis

What people are saying

Overall, the discussions reveal a positive outlook toward the publication, with many referencing the research findings and global market growth, highlighting a shared optimism about medicinal cannabis as a new avenue for pain relief. The tone is optimistic yet cautious, with phrases like 'new hope' and 'potential benefits,' demonstrating a recognition of the research's importance without dismissing ongoing concerns.

AgreementModerate agreement

Most discussions agree that medicinal cannabis offers potential benefits for managing dysmenorrhoea, as evidenced by positive keywords like 'hope' and references to clinical trials.

InterestHigh interest

Participants show high interest, with frequent mentions of clinical research, increasing global demand, and potential medical implications, reflected in words like 'potential,' 'research,' and 'market.'

EngagementModerate engagement

Posts demonstrate moderate engagement, with some discussions referencing recent studies, clinical trials, and policy implications, but lacking deep personal or detailed scientific discussion.

ImpactModerate impact

Overall, the discussions suggest recognition of the article's potential impact on women's health and medical treatments, considering the mention of the growing market and clinical benefits.

Abstract in brief

Up to 90% of women of reproductive age suffer from dysmenorrhoea, and current treatments mainly involve over-the-counter painkillers or hormonal methods.
Recent research suggests that medicinal cannabis, which contains compounds like cannabinoids, may help relieve pain associated with dysmenorrhoea, with most clinical trials showing positive outcomes but some side effects such as nausea and drowsiness.
The growing global market for medical cannabis, valued at USD 110 billion in 2021 and projected to grow significantly, is driving further research into its potential in managing pain and other clinical conditions.

Read the full abstract

All mentions

Ancient Medicines and the Modern Understanding of Cannabis' Anti-Inflammatory Properties

Ancient civilizations used herbal medicines, including cannabis, for thousands of years to treat inflammation. Recent studies highlight their potential in modulating the endocannabinoid system and reducing inflammatory…

Chronic Considerations · Sep 30, 2024 18 views

EndTheParanoia

@EndTheParanoia · X